Technical Analysis for AMLX - Amylyx Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| 20 DMA Resistance | Bearish | -2.67% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| 20 DMA Resistance | Bearish | 3.70% | |
| New 52 Week Closing Low | Bearish | 3.70% | |
| 180 Bearish Setup | Bearish Swing Setup | 3.70% | |
| Earnings Movers | Other | 3.70% | |
| Down 3 Days in a Row | Weakness | 3.70% | |
| Down 4 Days in a Row | Weakness | 3.70% | |
| Down 5 Days in a Row | Weakness | 3.70% |
| Alert | Time |
|---|---|
| Down 2 % | about 18 hours ago |
| Down 1% | about 19 hours ago |
| 60 Minute Opening Range Breakdown | about 19 hours ago |
| Possible NR7 | about 19 hours ago |
| 20 DMA Resistance | about 23 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Amylyx Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases in the United States and Canada. The company is developing AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and tauroursodeoxycholic acid for the treatment of ALS and other neurodegenerative diseases. It is also developing products for Wolfram syndrome and Alzheimer's diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Pharmaceutical Alzheimer's Disease Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Nervous System Apoptosis Neurodegenerative Disease
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Pharmaceutical Alzheimer's Disease Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Nervous System Apoptosis Neurodegenerative Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 27.99 |
| 52 Week Low | 1.7 |
| Average Volume | 3,945,311 |
| 200-Day Moving Average | 13.60 |
| 50-Day Moving Average | 3.07 |
| 20-Day Moving Average | 1.90 |
| 10-Day Moving Average | 1.91 |
| Average True Range | 0.21 |
| RSI (14) | 29.08 |
| ADX | 50.75 |
| +DI | 16.30 |
| -DI | 35.12 |
| Chandelier Exit (Long, 3 ATRs) | 1.50 |
| Chandelier Exit (Short, 3 ATRs) | 2.33 |
| Upper Bollinger Bands | 2.06 |
| Lower Bollinger Band | 1.73 |
| Percent B (%b) | 0.27 |
| BandWidth | 17.32 |
| MACD Line | -0.50 |
| MACD Signal Line | -0.68 |
| MACD Histogram | 0.1799 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.00 | ||||
| Resistance 3 (R3) | 2.02 | 1.98 | 1.97 | ||
| Resistance 2 (R2) | 1.98 | 1.93 | 1.97 | 1.96 | |
| Resistance 1 (R1) | 1.90 | 1.91 | 1.88 | 1.88 | 1.95 |
| Pivot Point | 1.86 | 1.86 | 1.85 | 1.85 | 1.86 |
| Support 1 (S1) | 1.78 | 1.81 | 1.76 | 1.76 | 1.69 |
| Support 2 (S2) | 1.74 | 1.79 | 1.73 | 1.68 | |
| Support 3 (S3) | 1.66 | 1.74 | 1.67 | ||
| Support 4 (S4) | 1.64 |
